Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, Roche Finance and Ascension Ventures all took part in the cancer data provider's latest round.

US-based cancer treatment data provider Syapse has secured $30m from investors including investment vehicles for pharmaceutical firms Amgen, Roche and Merck & Co, and care providers Ascension and Intermountain Healthcare.

Amgen Ventures, Ascension Ventures, Intermountain Ventures, Merck Global Health Innovation Fund and Roche Finance joined investment partnership Revelation Partners, which led the round through subsidiary Revelation Alpine, Safeguard Scientifics and Social Capital.

Founded in 2008, Syapse operates a network of healthcare data supported by a range of partners in the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn